3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Melanoma
19
Neuroblastoma
16
Leukemia
15
Prostatic Neoplasms
14
Lymphoma
12
Multiple Myeloma
10
Breast Neoplasms
10
Lymphoma, Non-Hodgkin
8
Leukemia, Myeloid, Acute
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Glioblastoma
8
Neoplasm Metastasis
6
Myelodysplastic Syndromes
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Fallopian Tube Neoplasms
6
Neoplasms
5
Hodgkin Disease
5
Carcinoma, Non-Small-Cell Lung
5
Uveal Melanoma
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Kidney Neoplasms
4
Glioma
4
Carcinoma, Renal Cell
4
Carcinoma, Ovarian Epithelial
4
Breast Neoplasms, Male
4
Ovarian Neoplasms
3
Neoplasms, Plasma Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Interventions
Temozolomide
44
Radiotherapy
20
Magnetic Resonance Spectroscopy
13
Irinotecan
13
Carboplatin
11
Bevacizumab
11
Filgrastim
9
Surgical Procedures, Operative
7
Procarbazine
6
sargramostim
5
Vincristine
5
Imatinib Mesylate
5
Etoposide
5
Erlotinib Hydrochloride
5
Carmustine
5
Biopsy
5
etoposide phosphate
4
Peripheral Blood Stem Cell Transplantation
4
Lomustine
4
Immunohistochemistry
4
Cyclophosphamide
4
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
4
temsirolimus
3
poly ICLC
3
aldesleukin
3
Thalidomide
3
Surveys and Questionnaires
3
Radiation
3
Polymerase Chain Reaction
3
Gadolinium DTPA
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Oligodendroglioma
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
NCT06254326
2026-05-27
ADAGiO
University of Florida
Phase 1
Recruiting
12 enrolled